L-Ornithine L-Aspartate 5g/10mL Infusion$144.00
1–9 boxes
$144.00 each
10–24 boxes
8% off
25+ boxes
10% off
L-Ornithine L-Aspartate 5g/10mL Infusion
SKU GME288Product Introduction
L-Ornithine L-Aspartate 5g/10mL Infusion is an ammonia-lowering treatment used in liver-related hepatic encephalopathy. It supports the removal of excess ammonia alongside treatment of the underlying liver condition and the factors triggering confusion or reduced alertness.
How to use
A healthcare professional dilutes the concentrate in a compatible infusion solution and gives it intravenously. It must not be injected into an artery. Nausea or vomiting during the infusion may require a slower rate. Mental state, kidney function and treatment response are monitored during ammonia-lowering treatment.
How it works
L-ornithine L-aspartate provides amino-acid substrates that support ammonia conversion through urea-cycle and glutamine-related pathways.
Side effects
Possible effects include nausea, vomiting, abdominal discomfort, diarrhea, and infusion-site discomfort. Seek review for worsening confusion, severe vomiting, allergic reaction, or reduced urination.
Important information
Do not use this infusion in severe kidney impairment. Tell the care team about pregnancy, breastfeeding and other hepatic-encephalopathy treatments. Infection, gastrointestinal bleeding, constipation and dehydration can trigger encephalopathy and may need separate treatment.
Uses
- Adjunctive management of hyperammonemia or hepatic encephalopathy related to liver disease when L-ornithine L-aspartate infusion is prescribed.
Benefits
May help lower ammonia burden and support improvement in encephalopathy symptoms as part of broader liver-care management.
Why can liver disease cause confusion or unusual sleepiness?
A severely impaired liver may not clear ammonia adequately. Ammonia and other changes can affect brain function, causing hepatic encephalopathy. Lowering ammonia is one part of treatment, alongside correcting the trigger.
Does L-Ornithine L-Aspartate 5g/10mL replace lactulose or rifaximin?
No. It may be used alongside standard treatment depending on the clinician's plan.
Why check kidney function?
Severe kidney impairment can affect nitrogen handling and may change suitability or dosing.
What symptoms are monitored?
Confusion, sleepiness, tremor or asterixis, ammonia-related features, vomiting, and overall liver status are monitored.
Is it a general liver tonic?
No. It is used for specific ammonia-related liver indications under medical supervision.
Hyperammonaemia: an abnormally high blood-ammonia level. Hepatic encephalopathy: changes in brain function associated with liver dysfunction. Urea cycle: a pathway that converts nitrogen waste into urea. Asterixis: a flapping movement that can occur when posture is maintained.; AR: L-Ornithine L-Aspartate 5g/10mL حقن; FR: L-Ornithine L-Aspartate 5g/10mL injection; PT: L-Ornithine L-Aspartate 5g/10mL injeção; ES: L-Ornithine L-Aspartate 5g/10mL inyección; RU: L-Ornithine L-Aspartate 5g/10mL инъекция; ID: L-Ornithine L-Aspartate 5g/10mL injeksi; VI: L-Ornithine L-Aspartate 5g/10mL thuốc tiêm; MS: L-Ornithine L-Aspartate 5g/10mL suntikan; TL: L-Ornithine L-Aspartate 5g/10mL iniksyon; ZH-SG: L-Ornithine L-Aspartate 5g/10mL 注射剂